Expertise in
4
conditions

Antoine Huart

Toulouse, FR 
Expertise in
4
conditions
Toulouse, FR 

Overview

Antoine Huart practices practicing medicine in Toulouse, France.

Mr. Huart is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Primary Amyloidosis, Cryoglobulinemia, Vasculitis, Glomerulonephritis, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 73 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Toulouse, France
Other Locations
Paris, France
Nantes, France
CH Côte Basque
Bayonne, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 2 Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis
Phase 2 Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis
Enrollment Status: Completed
Publish Date: April 16, 2025
Intervention Type: Drug
Study Drugs: Daratumumab, Bortezomib Injection, Dexamethasone oral tablet
Study Phase: Phase 2
Amyloidosis Typing Using Mass Spectrometry-based Proteomics: a New Accurate Tool for Difficult Typing
Amyloidosis Typing Using Mass Spectrometry-based Proteomics: a New Accurate Tool for Difficult Typing
Enrollment Status: Completed
Publish Date: July 12, 2023
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 1 Less Clinical Trial

73 Total Publications

Erratum: Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.
Erratum: Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 03, 2026

Frequently Asked Questions about Antoine Huart

Is Antoine Huart a top-rated expert for Primary Amyloidosis?

MediFind is an objective health platform that identifies experts based on real-world data. Antoine Huart is classified as an Distinguished expert for Primary Amyloidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Antoine Huart participate in research or clinical trials?

Yes. Antoine Huart has published 73 articles and abstracts on conditions like Primary Amyloidosis. You can view a list of Antoine Huart's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Huart's expertise for a condition
ConditionClose
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile